Teva Pharmaceutical Industries | TEVA - Los Gastos Financieros De La Deuda





Los Gastos Financieros De La Deuda Cambio Fecha
Aspen Pharmacare ZAR 631.5M 301.5M 2024-06
Cipla INR 170.3M 39M 2026-06
Dr.Reddys Laboratories INR 1.26B 198M 2026-06
Guangzhou Baiy CNY 102.39M 780K 2025-06
Jiangsu Hengrui CNY 254.59M 253.85M 2025-09
Kalbe Farma IDR 9.69B 689.63M 2025-09
Richter Gedeon HUF 7.5B 9.53B 2024-09
Sh Fosun Pharma CNY 321.25M 2M 2025-09
Sun Pharmaceuticals INR 859M 139.6M 2026-03
Teva Pharmaceutical Industries USD 195M 21M 2026-06